Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure

Gerontology

Volumn 47, Issue 1, 2001, Pages 46-51

  Tamura, Koji ^a,c   Takahashi, Nobuyuki ^b   Nakatani, Yuko ^a   Onishi, Satoshi ^a   Iwasaka, Toshiji ^b  

^a Keihanna Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c Keihanna Hospital   (Japan)

Author keywords

Brain natriuretic peptide; Elderly; Left ventricular ejection fraction; Left ventricular mass index; New York Heart Association functional class

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; STATIN;

AGED; AGING; ARTICLE; BLOOD PRESSURE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME INHIBITION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MALE; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RATING SCALE; REGRESSION ANALYSIS;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0035103434     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052769     Document Type: Article

References (20)

1. A new natriuretic peptide in porcine brain
2. Brain natriuretic peptide as a novel cardiac hormone in humans
3. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
4. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure
5. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction
6. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy
7. Relation between left ventricular geometry and natriuretic peptide levels in essential hypertension
8. Measurement and significance of circulating natriuretic peptides in cardiovascular disease
9. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
10. Brain natriuretic peptide in an elderly population
11. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements
12. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
13. Plasma brain natriuretic peptide as a biochemical marker of high ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
14. Prognosis of congestive heart failure and predictors of mortality
15. Predictors of total mortality and sudden death in mild to moderate heart failure
16. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
17. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide
18. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction
19. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
20. High- versus low-dose ACE inhibition in chronic heart failure: A double-blind, placebo-controlled study of imidapril